Health
South African SARS-CoV-2 variant neutralized by two Chinese vaccines in case study – News-Medical.Net
A new study offers some reassuring findings, reporting the successful neutralization of the South African SARS-CoV-2 variant of concern (VOC) 501Y.V2 by two vaccines…
As public health authorities and governments struggle to turn to the tide of the coronavirus disease 2019 (COVID-19) pandemic, caused by the severe acute respiratory syndrome coronavirus 2 (COVID-19), newly emerged and highly infectious variants place increased stress on containment measures.
Newly approved vaccines are being distributed to millions the world over, but concern is mounting over whether they will elicit antibodies capable of neutralizing the new variants with their array of mutations.
…
-
Business22 hours agoForget CBA and buy these high-yield ASX dividend shares
-
Business23 hours agoTop brokers name 3 ASX shares to buy next week 6 April 2025
-
Business22 hours agoHere’s a starter portfolio of ASX 200 shares to consider for growth, dividends, and value!
-
Noosa News22 hours agoThe Almond Ashes sees Australia and India mix business and cricket